Cooper Companies (NASDAQ:COO) Stock Crosses Above Two Hundred Day Moving Average – What’s Next?

The Cooper Companies, Inc. (NASDAQ:COO) shares crossed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $71.22 and traded as high as $76.14. Cooper Companies shares last traded at $75.10, with a volume of 1,928,063 shares traded.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on the stock. Piper Sandler set a $86.00 price objective on shares of Cooper Companies and gave the company an “overweight” rating in a report on Monday, June 1st. UBS Group started coverage on shares of Cooper Companies in a report on Tuesday, July 28th. They set a “neutral” rating and a $75.00 target price for the company. Wells Fargo & Company reaffirmed a “sell” rating and issued a $66.00 price target (down from $82.00) on shares of Cooper Companies in a report on Friday, June 5th. JPMorgan Chase & Co. cut their price target on Cooper Companies from $80.00 to $71.00 and set a “neutral” rating on the stock in a research report on Friday, June 5th. Finally, Weiss Ratings lowered Cooper Companies from a “hold (c-)” rating to a “sell (d)” rating in a research note on Monday, June 8th. One investment analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, six have issued a Hold rating and three have given a Sell rating to the company. Based on data from MarketBeat, Cooper Companies currently has an average rating of “Hold” and a consensus price target of $81.64.

Cooper Companies Stock Up 0.9%

The company has a debt-to-equity ratio of 0.23, a quick ratio of 0.78 and a current ratio of 1.27. The firm has a market cap of $14.78 billion, a price-to-earnings ratio of 64.20, a PEG ratio of 1.99 and a beta of 0.83. The business’s 50 day moving average price is $71.41 and its 200 day moving average price is $71.18.

Cooper Companies (NASDAQ:COO) last posted its earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.10 by $0.11. The firm had revenue of $1.08 billion during the quarter, compared to analysts’ expectations of $1.05 billion. Cooper Companies had a net margin of 5.57% and a return on equity of 10.88%. The business’s revenue was up 7.9% compared to the same quarter last year. During the same period in the previous year, the business posted $0.96 EPS. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. On average, equities analysts forecast that The Cooper Companies, Inc. will post 4.63 EPS for the current year.

Hedge Funds Weigh In On Cooper Companies

Several institutional investors and hedge funds have recently modified their holdings of COO. Avalon Trust Co purchased a new position in Cooper Companies during the second quarter worth approximately $25,000. Root Financial Partners LLC lifted its position in shares of Cooper Companies by 104.5% during the 4th quarter. Root Financial Partners LLC now owns 317 shares of the medical device company’s stock valued at $26,000 after buying an additional 162 shares in the last quarter. SJS Investment Consulting Inc. grew its stake in Cooper Companies by 107.5% in the 1st quarter. SJS Investment Consulting Inc. now owns 361 shares of the medical device company’s stock valued at $26,000 after acquiring an additional 187 shares during the period. Elevation Wealth Partners LLC increased its holdings in Cooper Companies by 1,136.4% in the 2nd quarter. Elevation Wealth Partners LLC now owns 408 shares of the medical device company’s stock worth $29,000 after acquiring an additional 375 shares in the last quarter. Finally, J.Safra Asset Management Corp acquired a new position in Cooper Companies during the second quarter worth $32,000. Hedge funds and other institutional investors own 24.39% of the company’s stock.

About Cooper Companies

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.